3rd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$119,827
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Graduate Medical Education; Resident Physician Shortage Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); White House Office; Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Executive Office of the President (EOP)

Budget/Appropriations BUD

National Health Service Corp; Community Health Centers; Health Resource & Services Administration

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); White House Office; Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP)

Health Issues HCR

Medicare Physician Payment Reform; Physician Workforce

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); White House Office; Office of Management & Budget (OMB); SENATE; Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); White House Office; Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Government Accountability Office (GAO); SENATE; Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ)

Taxation/Internal Revenue Code TAX

Health Savings Accounts; Primary Care Enhancement Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: White House Office; Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Food & Drug Administration (FDA); Government Accountability Office (GAO); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Insurance INS

Professional Liability Insurance; Health Insurance

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); White House Office; Medicare Payment Advisory Commission (MedPAC)

Education EDU

Teaching Health Center Graduate Medical Education; National Health Service Corps; Foreign Medical School Accountability Fairness Act; Single Accreditation

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); Office of Management & Budget (OMB); Government Accountability Office (GAO); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ)

Medical/Disease Research/Clinical Labs MED

NIH, FDA

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Executive Office of the President (EOP); SENATE; Medicare Payment Advisory Commission (MedPAC); White House Office; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB)

Torts TOR

Protecting Access to Care Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); White House Office; Office of Management & Budget (OMB)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.